```html

Disseminated Intravascular Coagulation (DIC) – A Patient‑Friendly Guide

Overview

Disseminated intravascular coagulation (DIC) is a serious, acquired disorder in which the body’s normal clotting system becomes over‑active. Tiny clots form throughout the bloodstream, using up clotting factors and platelets. When these resources are exhausted, the same patient can suddenly bleed from wounds, mucous membranes, or internal organs.

Who it affects: DIC can occur at any age, but it is most common in adults who are hospitalized for severe illness. It is especially seen in patients with sepsis, trauma, obstetric complications, certain cancers, and severe allergic reactions.

Prevalence: Exact numbers are hard to pin down because DIC is usually a complication of another condition. In the United States, DIC is reported in approximately 1–4% of intensive‑care unit (ICU) admissions and up to 35% of patients with severe sepsis.<sup>[1] CDC, 2022</sup> Mortality rates range from 20% to 50% depending on the underlying cause.<sup>[2] Mayo Clinic, 2023</sup>

Symptoms

DIC can evolve rapidly, and symptoms reflect both clotting and bleeding. Not every patient experiences all of them.

Signs of Excessive Clotting

• Skin discoloration (purpura or petechiae): Small red or purple spots that do not blanch with pressure.
• Peripheral cyanosis or mottling: A “marble‑like” appearance of the skin.
• Organ dysfunction: Confusion, decreased urine output, or shortness of breath due to micro‑thrombi in the brain, kidneys, or lungs.

Signs of Bleeding

• Bleeding from venipuncture sites or catheters.
• Gum, nose, or gastrointestinal bleeding.
• Hematuria (blood in urine) or melena (black, tarry stools).
• Excessive bruising or spontaneous large bruises.
• Vaginal bleeding (in women) that is heavier than a normal period.

Systemic Symptoms

• Fever, chills, or shock – often reflecting the underlying trigger (e.g., sepsis).
• Rapid heart rate and low blood pressure.
• Sudden drop in oxygen saturation if pulmonary micro‑thrombi develop.

Causes and Risk Factors

DIC is never an isolated disease; it is a secondary reaction to another severe problem. The most common precipitants are:

Infections

• Severe bacterial sepsis (especially gram‑negative organisms) – the leading cause in Western hospitals.<sup>[3] WHO, 2021</sup>
• Viral hemorrhagic fevers (Ebola, Dengue) and severe COVID‑19.

Trauma and Surgery

• Massive tissue injury, crush injuries, or extensive burns.
• Major cardiac or vascular surgery, especially with cardiopulmonary bypass.

Obstetric Complications

• Placental abruption, amniotic fluid embolism, or severe postpartum hemorrhage.
• Intra‑uterine fetal death.

Cancers

• Acute promyelocytic leukemia (APL) – a classic hematologic trigger.
• Advanced solid tumors (pancreatic, gastric, lung) that release pro‑coagulant substances.

Other Triggers

• Severe allergic or anaphylactic reactions.
• Snake venom or certain toxins.
• Massive hemolysis (e.g., after a large transfusion reaction).

Risk Factors that Increase Susceptibility

• Immunocompromised state (HIV, chemotherapy).
• Pre‑existing coagulation disorders.
• Advanced age – older adults have a blunted ability to regulate coagulation.
• Pregnancy (particularly in the third trimester) due to physiologic hypercoagulability.

Diagnosis

DIC is diagnosed by clinical suspicion plus a panel of laboratory tests that reveal a pattern of simultaneous clotting and bleeding.

Key Laboratory Findings

• Platelet count: Usually low (<150 × 10⁹/L) because platelets are consumed.
• Prothrombin time (PT) & activated partial thromboplastin time (aPTT): Both are prolonged, indicating depletion of clotting factors.
• Fibrinogen level: Decreased (<1 g/L) as fibrin is used up to form clots.
• D‑dimer and fibrin‑degradation products (FDP): Markedly elevated, reflecting breakdown of widespread clots.
• Peripheral blood smear: May show schistocytes (fragmented red cells) due to mechanical damage from micro‑thrombi.

Scoring Systems

The International Society on Thrombosis and Haemostasis (ISTH) provides a scoring algorithm that assigns points for platelet count, fibrin‑related markers, PT prolongation, and fibrinogen level. A score ≥5 suggests overt DIC.<sup>[4] ISTH, 2020</sup>

Imaging (when needed)

• CT or MRI to evaluate organ infarction (e.g., renal or cerebral).
• Ultrasound for unexplained abdominal bleeding.

Important Diagnostic Tip

Because DIC evolves quickly, repeat labs every 6‑12 hours are often required to track progression and guide therapy.

Treatment Options

Treating DIC focuses on two pillars: addressing the underlying cause and supporting the coagulation system. No single drug “cures” DIC.

1. Treat the Trigger

• Sepsis: Broad‑spectrum antibiotics within the first hour, source control (drainage, debridement), and aggressive fluid resuscitation.
• Obstetric emergencies: Immediate delivery or obstetric management, replacement of lost blood.
• Leukemia: Induction chemotherapy (e.g., all‑trans retinoic acid for APL) combined with supportive care.

2. Replace Consumated Blood Components

• Platelet transfusion: Target > 50 × 10⁹/L for patients with bleeding or undergoing invasive procedures.
• Fresh frozen plasma (FFP): Provides clotting factors; dose 10–15 mL/kg if PT/aPTT > 1.5× normal.
• Cryoprecipitate: Gives fibrinogen; give 2–4 units to raise fibrinogen > 1.5 g/L.
• Recombinant factor VIIa: Reserved for life‑threatening hemorrhage when conventional therapy fails; use under specialist supervision because of thrombosis risk.

3. Anticoagulation (Selective)

Paradoxically, low‑dose heparin may be used in patients with predominant thrombosis and minimal bleeding, especially in chronic DIC (e.g., associated with solid tumors). Routine anticoagulation is NOT recommended for acute, bleeding‑dominant DIC.

4. Adjunctive Therapies

• Tranexamic acid: May help control mucosal bleeding if fibrinolysis is excessive; avoid if active thrombosis is present.
• Vitamin K: Only useful if deficiency is suspected (e.g., warfarin overdose).
• Supportive ICU care: Mechanical ventilation, vasopressors, renal replacement therapy as required.

5. Lifestyle / Long‑Term Management

For patients who have recovered from an acute episode but have a chronic underlying disease (e.g., cancer), regular monitoring of coagulation labs and prompt treatment of infections are essential.

Living with Disseminated Intravascular Coagulation (DIC)

Even after the acute phase resolves, patients often need ongoing vigilance.

Daily Management Tips

• Medication adherence: Take antibiotics, chemotherapy, or anticoagulants exactly as prescribed.
• Bleeding precautions: Use a soft toothbrush, electric razor, and avoid contact sports.
• Skin care: Keep skin clean and moisturized; report new bruises or petechiae promptly.
• Hydration and nutrition: Adequate fluids support kidney function; protein‑rich diet helps rebuild clotting factors.
• Regular labs: Follow up with your hematologist for CBC, PT/INR, aPTT, fibrinogen, and D‑dimer every 1–2 weeks (or as directed).
• Vaccinations: Stay up‑to‑date on influenza, pneumococcal, and COVID‑19 vaccines to reduce infection risk.

Emotional & Social Support

Living with a condition that can cause rapid deterioration is stressful. Consider:

• Joining a support group for patients with clotting disorders.
• Speaking with a mental‑health professional about anxiety or depression.
• Keeping a symptom diary to share with your care team.

Prevention

Because DIC is secondary, prevention focuses on minimizing the risk of the underlying triggers.

• Infection control: Hand hygiene, timely vaccination, and early treatment of fevers.
• Safe obstetric care: Prenatal monitoring for placental problems, prompt management of postpartum hemorrhage.
• Trauma avoidance: Use seatbelts, helmets, and protective equipment.
• Cancer surveillance: Follow screening guidelines (colon, breast, lung, cervical) to catch malignancies early.
• Medication safety: Avoid unnecessary over‑the‑counter NSAIDs or herbs that can interfere with platelet function unless cleared by a physician.

Complications

If DIC is not recognized or treated promptly, the following life‑threatening complications may develop:

• Multiorgan failure: Kidneys, liver, lungs, and brain can suffer from micro‑vascular occlusion.
• Severe hemorrhage: Intracranial, gastrointestinal, or intra‑abdominal bleeding leading to shock.
• Thrombotic events: Deep‑vein thrombosis, pulmonary embolism, or arterial strokes.
• Disseminated skin necrosis: Especially in cases with severe peripheral micro‑thrombi.
• Amputations: Rare, but possible if limb ischemia is prolonged.

When to Seek Emergency Care

---

References:
[1] Centers for Disease Control and Prevention. “Sepsis and DIC in ICU Patients.” 2022.
[2] Mayo Clinic. “Disseminated Intravascular Coagulation (DIC).” Updated 2023.
[3] World Health Organization. “Hemostasis Disorders: Global Burden.” 2021.
[4] ISTH. “Scoring System for DIC.” 2020.
Additional information drawn from NIH National Heart, Lung, and Blood Institute and Cleveland Clinic resources.

```